RNA splicing and editing modulation of 5-HT2C receptor function: Relevance to anxiety and aggression in VGV mice

Molecular Psychiatry

Volumn 18, Issue 6, 2013, Pages 656-665

  Martin, C B P ^a   Ramond, F ^b   Farrington, D T ^c   Aguiar, A S ^d   Chevarin, C ^a   Berthiau, A S ^b   Caussanel, S ^b   Lanfumey, L ^a   Herrick Davis, K ^e   Hamon, M ^a   Madjar, J J ^b   Mongeau, R ^a  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

^c WADSWORTH CENTER   (United States)

^d FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^e ALBANY MEDICAL COLLEGE   (United States)

Author keywords

2,4 dinitrophenol; anxiety; depression; heterodimer; serotonin

Indexed keywords

SEROTONIN 2C RECEPTOR;

AGGRESSION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; BRAIN REGION; CELL MEMBRANE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FLUORESCENCE RESONANCE ENERGY TRANSFER; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA SPLICING; SOCIAL INTERACTION;

AGGRESSION; ANIMALS; ANXIETY; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER TECHNIQUES; BRAIN; DEFENSE MECHANISMS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLYCINE; HEK293 CELLS; HUMANS; HYDROXYINDOLEACETIC ACID; INTERPERSONAL RELATIONS; MICE; MICE, INBRED C57BL; MUTATION; PHENYLALANINE; PROTEIN BINDING; PROTEIN ISOFORMS; RECEPTOR, SEROTONIN, 5-HT2C; RNA EDITING; RNA PRECURSORS; RNA SPLICING; RNA, MESSENGER; TRANSFECTION; ULTRASONICS; VALINE;

EID: 84878231589     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2012.171     Document Type: Article

References (62)

1. Oquendo MA, Mann JJ. The biology of impulsivity and suicidality. Psychiatr Clin North Am 2000; 23: 11-25.
2. Ryding E, Lindstrom M, Traskman-Bendz L. The role of dopamine and serotonin in suicidal behaviour and aggression. Prog Brain Res 2008; 172: 307-315.
3. Liu S, Bubar MJ, Lanfranco MF, Hillman GR, Cunningham KA. Serotonin2C receptor localization in GABA neurons of the rat medial prefrontal cortex: implications for understanding the neurobiology of addiction. Neuroscience 2007; 146: 1677-1688.
4. Mongeau R, Martin CB, Chevarin C, Maldonado R, Hamon M, Robledo P et al. 5-HT(2c) receptor activation prevents stress-induced enhancement of brain 5-HT turnover and extracellular levels in the mouse brain: modulation by chronic paroxetine treatment. J Neurochem 2010; 115: 438-449.
5. Ghaziuddin N, King CA, Welch KB, Zaccagnini J, Weidmer-Mikhail E, Mellow AM et al. Serotonin dysregulation in adolescents with major depression: hormone response to meta-chlorophenylpiperazine (mCPP) infusion. Psychiatry Res 2000; 95: 183-194.
6. Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, van Praag HM. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects. Psychiatry Res 1991; 37: 25-34.
7. Van Veen JF, Van der Wee NJ, Fiselier J, Van Vliet IM, Westenberg HG. Behavioural effects of rapid intravenous administration of meta- chlorophenylpiperazine (m-CPP) in patients with generalized social anxiety disorder, panic disorder and healthy controls. Eur Neuropsychopharmacol 2007; 17: 637-642.
8. de Leeuw AS, Westenberg HG. Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlor-ophenylpiperazine and pre-treatment with ritanserin and placebo. J Psychiatr Res 2008; 42: 894-901.
9. Videtic A, Peternelj TT, Zupanc T, Balazic J, Komel R. Promoter and functional polymorphisms of HTR2C and suicide victims. Genes Brain Behav 2009; 8: 541-545.
10. Mazza M, Mandelli L, Martinotti G, Di NM, Tavian D, Negri G et al. Further evidence supporting the association between 5HTR2C gene and bipolar disorder. Psychiatry Res 2010; 180: 151-152.
11. Kuhn KU, Joe AY, Meyer K, Reichmann K, Maier W, Rao ML et al. Neuroimaging and 5-HT2C receptor polymorphism: a HMPAO-SPECT study in healthy male probands using mCPP-challenge of the 5-HT2C receptor. Pharmacopsychiatry 2004; 37: 286-291.
12. Pandey GN, Dwivedi Y, Ren X, Rizavi HS, Faludi G, Sarosi A et al. Regional distribution and relative abundance of serotonin(2c) receptors in human brain: effect of suicide. Neurochem Res 2006; 31: 167-176.
13. McGrew L, Price RD, Hackler E, Chang MS, Sanders-Bush E. RNA editing of the human serotonin 5-HT2C receptor disrupts transactivation of the small G-protein RhoA. Mol Pharmacol 2004; 65: 252-256.
14. Niswender CM, Copeland SC, Herrick-Davis K, Emeson RB, Sanders-Bush E. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem 1999; 274: 9472-9478.
15. Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, Schmauss C. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 2002; 34: 349-356.
16. Niswender CM, Herrick-Davis K, Dilley GE, Meltzer HY, Overholser JC, Stockmeier CA et al. RNA editing of the human serotonin 5-HT2C receptor. Alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsycho-pharmacology 2001; 24: 478-491.
17. Iwamoto K, Kato T. RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci Lett 2003; 346: 169-172.
18. Kawahara Y, Grimberg A, Teegarden S, Mombereau C, Liu S, Bale TL et al. Dys-regulated editing of serotonin 2C receptor mRNAs results in energy dissipation and loss of fat mass. J Neurosci 2008; 28: 12834-12844.
19. Olaghere da Silva UB, Morabito MV, Canal CE, Airey DC, Emeson RB, Sanders-Bush E. Impact of RNA editing on functions of the serotonin 2C receptor in vivo. Front Neurosci 2010; 4: 26.
20. Flomen R, Knight J, Sham P, Kerwin R, Makoff A. Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene. Nucleic Acids Res 2004; 32: 2113-2122.
21. Canton H, Emeson RB, Barker EL, Backstrom JR, Lu JT, Chang MS et al. Identification, molecular cloning, and distribution of a short variant of the 5-hydro-xytryptamine2C receptor produced by alternative splicing. Mol Pharmacol 1996; 50: 799-807.
22. Dracheva S, Chin B, Haroutunian V. Altered serotonin 2C receptor RNA splicing in suicide: association with editing. Neuroreport 2008; 19: 379-382.
23. Morabito MV, Abbas AI, Hood JL, Kesterson RA, Jacobs MM, Kump DS et al. Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Neurobiol Dis 2010; 39: 169-180.
24. Mombereau C, Kawahara Y, Gundersen BB, Nishikura K, Blendy JA. Functional relevance of serotonin 2C receptor mRNA editing in antidepressant-and anxietylike behaviors. Neuropharmacology 2010; 59: 468-473.
25. Harper JA, Dickinson K, Brand MD. Mitochondrial uncoupling as a target for drug development for the treatment of obesity. Obes Rev 2001; 2: 255-265.
26. Christianson JP, Ragole T, Amat J, Greenwood BN, Strong PV, Paul ED et al. 5-hydroxytryptamine 2C receptors in the basolateral amygdala are involved in the expression of anxiety after uncontrollable traumatic stress. Biol Psychiatry 2010; 67: 339-345.
27. Mongeau R, Miller GA, Chiang E, Anderson DJ. Neural correlates of competing fear behaviors evoked by an innately aversive stimulus. J Neurosci 2003; 23: 3855-3868.
28. Yu HJ, Yamaguchi A. Endogenous serotonin acts on 5-HT2C-like receptors in key vocal areas of the brain stem to initiate vocalizations in Xenopus laevis. J Neu-rophysiol 2010; 103: 648-658.
29. Leung PK, Chow KB, Lau PN, Chu KM, Chan CB, Cheng CH et al. The truncated ghrelin receptor polypeptide (GHS-R1b) acts as a dominant-negative mutant of the ghrelin receptor. Cell Signal 2007; 19: 1011-1022.
30. Herrick-Davis K, Grinde E, Mazurkiewicz JE. Biochemical and biophysical characterization of serotonin 5-HT2C receptor homodimers on the plasma membrane of living cells. Biochemistry 2004; 43: 13963-13971.
31. Herrick-Davis K, Grinde E, Weaver BA. Serotonin 5-HT(2C) receptor homo-dimerization is not regulated by agonist or inverse agonist treatment. Eur J Pharmacol 2007; 568: 45-53.
32. Nadam J, Navarro F, Sanchez P, Moulin C, Georges B, Laglaine A et al. Neuro-protective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus. Neurobiol Dis 2007; 25: 412-426.
33. Doe CM, Relkovic D, Garfield AS, Dalley JW, Theobald DE, Humby T et al. Loss of the imprinted snoRNA mbii-52 leads to increased 5htr2c pre-RNA editing and altered 5HT2CR-mediated behaviour. Hum Mol Genet 2009; 18: 2140-2148.
34. Du Y, Stasko M, Costa AC, Davisson MT, Gardiner KJ. Editing of the serotonin 2C receptor pre-mRNA: effects of the morris water maze. Gene 2007; 391: 186-197.
35. Aloyo VJ, Harvey JA. Antagonist binding at 5-HT(2A) and 5-HT(2C) receptors in the rabbit: high correlation with the profile for the human receptors. Eur J Pharmacol 2000; 406: 163-169.
36. Caldeira da Silva CC, Cerqueira FM, Barbosa LF, Medeiros MH, Kowaltowski AJ. Mild mitochondrial uncoupling in mice affects energy metabolism, redox balance and longevity. Aging Cell 2008; 7: 552-560.
37. Bagdy G, Graf M, Anheuer ZE, Modos EA, Kantor S. Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol 2001; 4: 399-408.
38. Dekeyne A, Denorme B, Monneyron S, Millan MJ. Citalopram reduces social interaction in rats by activation of serotonin (5-HT)(2C) receptors. Neuropharma-cology 2000; 39: 1114-1117.
39. Martin CBP, Hamon M, Lanfumey L, Mongeau R. The role of 5-HT2C receptors in the antidepressant response: a critical review. In: Cryan JF, Leonard BE (eds) Psychopathology and Pharmacotherapy of Depression: Recent Advances and Future Needs. Karger: Basel, pp 155-181, 2010.
40. Bubar MJ, Cunningham KA. Distribution of serotonin 5-HT2C receptors in the ventral tegmental area. Neuroscience 2007; 146: 286-297.
41. Kishore S, Stamm S. Regulation of alternative splicing by snoRNAs. Cold Spring Harb Symp Quant Biol 2006; 71: 329-334.
42. Marion S, Weiner DM, Caron MG. RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine 2c receptor isoforms. J Biol Chem 2004; 279: 2945-2954.
43. Herrick-Davis K, Grinde E, Niswender CM. Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction. J Neurochem 1999; 73: 1711-1717.
44. Kimura A, Stevenson PL, Carter RN, Maccoll G, French KL, Paul SJ et al. Over-expression of 5-HT2C receptors in forebrain leads to elevated anxiety and hypoactivity. Eur J Neurosci 2009; 30: 299-306.
45. Harada K, Yamaji T, Matsuoka N. Activation of the serotonin 5-HT2C receptor is involved in the enhanced anxiety in rats after single-prolonged stress. Pharmacol Biochem Behav 2008; 89: 11-16.
46. Martinez RC, Carvalho-Netto EF, Ribeiro-Barbosa ER, Baldo MV, Canteras NS. Amygdalar roles during exposure to a live predator and to a predator-associated context. Neuroscience 2011; 172: 314-328.
47. Burghardt NS, Bush DE, McEwen BS, LeDoux JE. Acute selective serotonin reup-take inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist. Biol Psychiatry 2007; 62: 1111-1118.
48. Serretti A, Mandelli L, Giegling I, Schneider B, Hartmann AM, Schnabel A et al. HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 291-299.
49. Virkkunen M, Goldman D, Linnoila M. Serotonin in alcoholic violent offenders. Ciba Found Symp 1996; 194: 168-177.
50. Klaassen T, Riedel WJ, van Praag HM, Menheere PP, Griez E. Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression. Psychiatry Res 2002; 113: 29-40.
51. Lidberg L, Tuck JR, Asberg M, Scalia-Tomba GP, Bertilsson L. Homicide, suicide and CSF 5-HIAA. Acta Psychiatr Scand 1985; 71: 230-236.
52. Jordan BA, Devi LA. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999; 399: 697-700.
53. Herrick-Davis K, Grinde E, Harrigan TJ, Mazurkiewicz JE. Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein. J Biol Chem 2005; 280: 40144-40151.
54. Karpa KD, Lin R, Kabbani N, Levenson R. The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors. Mol Pharmacol 2000; 58: 677-683.
55. Scarselli M, Novi F, Corsini GU, Maggio R. Functional rescue of the inactive splice variant of the dopamine D3 receptor D3nf. Brain Res 2003; 987: 244-247.
56. Pritchard LM, Logue AD, Taylor BC, Ahlbrand R, Welge JA, Tang Y et al. Relative expression of D3 dopamine receptor and alternative splice variant D3nf mRNA in high and low responders to novelty. Brain Res Bull 2006; 70: 296-303.
57. Schmauss C. Enhanced cleavage of an atypical intron of dopamine D3-receptor pre-mRNA in chronic schizophrenia. J Neurosci 1996; 16: 7902-7909.
58. Dracheva S, Elhakem SL, Marcus SM, Siever LJ, McGurk SR, Haroutunian V. RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia. J Neurochem 2003; 87: 1402-1412.
59. Guest PC, Salim K, Skynner HA, George SE, Bresnick JN, McAllister G. Identification and characterization of a truncated variant of the 5-hydroxytryptamine(2A) receptor produced by alternative splicing. Brain Res 2000; 876: 238-244.
60. Olsen MA, Nawoschik SP, Schurman BR, Schmitt HL, Burno M, Smith DL et al. Identification of a human 5-HT6 receptor variant produced by alternative splicing. Brain Res Mol Brain Res 1999; 64: 255-263.
61. Deraet M, Manivet P, Janoshazi A, Callebert J, Guenther S, Drouet L et al. The natural mutation encoding a C terminus-truncated 5-hydroxytryptamine 2B receptor is a gain of proliferative functions. Mol Pharmacol 2005; 67: 983-991.
62. Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E et al. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 1997; 387: 303-308.